Executive Director, Head of Japan Medical Affairs

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

Reporting to the President and Representative Director Japan the Executive Director & Head of Japan Medical Affairs will lead the development and execution of RevMeds Medical Affairs strategy in Japan ensuring alignment with global and regional objectives and local needs. This leadership role is critical to maximizing the opportunity for RevMed Innovation to impact patients in collaboration with the President and Representative Director Japan and the SVP Head of Global Medical Affairs the successful medical leader will develop and execute comprehensive medical strategies to accelerate engagement with Japan key stakeholders (government authorities regulatory authorities payer authorities physicians). As a member of the Japan Leadership Team collaborate closely across functions to set and execute the strategy for Japan.

This leader will ensure that Japans medical considerations are embedded in the global medical strategy and plans and will partner with the VP Head of Japan and market access teams to ensure that reimbursement and access considerations are integrated in the existing and future clinical program design of the company portfolio/pipeline. The incumbent will be responsible for building and leading the Japan medical affairs team working closely across Med Affairs functions including Med Info Pharmacovigilance & HEOR.

Responsibilities:

• Lead the development and execution of the Japan Medical Affairs strategy for RevMeds portfolio ensuring alignment with global objectives and local market needs.

• As directed by the overall RevMed go to market strategy build and lead the Japan Medical Affairs team working with cross-functional leaders to ensure that each team member and function executes against the clear and well-aligned business objectives.

• Serve as the Japan medical expert across the oncology portfolio providing guidance and close partnership with clinical development clinical operations market access regulatory strategy and commercialization plans.

• Work with the global team to drive country scientific communication activities including publication planning congress strategy and development of medical education programs.

• Provide medical insight and leadership on cross-functional teams including Global Medical Affairs Japan Regulatory Affairs Clinical Development & Clinical Operations Commercial Market Access and Safety.

• Ensure all medical activities adhere to ethical regulatory and compliance standards.

• Support the medical review of promotional materials and contribute to internal training and capability building for oncology medical teams.

• Develop and manage the Japan Region Medical Affairs budget in alignment with the President and Representative Director Japan.

• Foster a culture consistent with the global RevMed values and vision/mission.

Clinical Collaboration in line with regulatory/compliance requirements:

• Collaborate cross-functionally to initiate and support clinical trials in Japan ensuring adherence to regulatory guidelines and timelines.

• Work closely with clinical operations medical affairs market access and regulatory teams to facilitate smooth startup and execution.

• Provide strategic input to global teams on the selection of endpoints comparators patient populations and study designs to ensure clinical trials generate meaningful data.

• Support the groundwork for Phase I-III clinical trials by identifying potential clinical trial sites establishing relationships with investigators and supporting preparation of regulatory submissions.

Establish and maintain collaborative relationships with Key Opinion Leaders (KOLs) academic institutions cooperative groups professional societies and healthcare providers.

• Develop and maintain strong relationships with Key Opinion Leaders (KOLs) in the fields of pancreatic lung and other cancers.

• Engage with KOLs to gather insights validate clinical development plans and support market development activities.

• Leverage KOL relationships to enhance the companys scientific and commercial credibility in Japan/APAC markets.

• Build and maintain relationships with other key stakeholders including healthcare professionals and organizations country and region regulatory bodies patient advocacy groups and industry partners.

• Facilitate effective communication between internal teams and external partners to align goals and expectations.

• Represent the company at international and APAC conferences industry events and regulatory meetings to promote our cell therapy products and company mission.

Collaborate to support Access and other key functions

• Oversee medical input into HTA studies as well as any HTA submissions to support value access and pricing in Japan throughout the product lifecycle as needed.

• Provide regional input into the design of Real-World Evidence (RWE) initiatives Phase IV studies and Investigator-Sponsored or Collaborative Research.

• Work closely with Commercial Head and Safety/PV Head to ensure field teams are prepared to interact with key customers and comply with Japan regulations as it relates to safety data collection etc.

Required Skills Experience and Education:

• Advanced scientific degree required (MD PhD or PharmD) with a specialization or significant experience in oncology.

• Minimum 10 years of relevant experience in Medical Affairs within oncology including country regional or global leadership roles.

• Proven ability to lead medical strategy and engage effectively with external oncology experts and stakeholders.

• Demonstrated ability to build and lead a high-performing medical affairs team.

• Strong leadership and influencing skills with the ability to create a clear sense of direction.

• Strong knowledge of the Japan oncology landscape including regulatory frameworks treatment guidelines and reimbursement pathways.

• Experience with scientific data generation clinical trial interpretation and communication of complex data to diverse audiences.

• Ability to create and nurture a strong culture of collaboration and authenticity to extend and replicate the RevMed culture at the regional level.

• Highly organized and motivated individual possessing excellent communication presentation and interpersonal skills.

• Strong team orientation and passion for continuous self and team development.

• Ability to flexibly lead; willingness to learn new therapeutic areas and technologies.

• Thrives in a fast-paced dynamic small company environment and able to adjust priorities and workload based upon changing needs.

Preferred Skills:

• Experience with oncology launches is desired.

• Experience in gastrointestinal and lung cancers preferred.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect process and use any personal data that you provide to us in accordance with ourCCPA additional information please contact.